RACHEL SCHIFF

Concepts (507)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
128
2025
2752
11.010
Why?
Receptor, ErbB-2
54
2025
559
7.780
Why?
Drug Resistance, Neoplasm
62
2025
803
7.550
Why?
Receptors, Estrogen
57
2024
822
6.470
Why?
Antineoplastic Agents, Hormonal
38
2022
271
4.440
Why?
Estrogen Receptor alpha
21
2022
472
3.430
Why?
Tamoxifen
35
2022
374
3.380
Why?
Trastuzumab
26
2025
154
2.530
Why?
Antineoplastic Combined Chemotherapy Protocols
16
2025
1349
2.410
Why?
Quinazolines
20
2023
183
2.280
Why?
Signal Transduction
55
2025
4867
1.930
Why?
Antineoplastic Agents
24
2022
1838
1.870
Why?
Gene Expression Regulation, Neoplastic
39
2024
2110
1.630
Why?
Cell Line, Tumor
56
2025
3704
1.460
Why?
ErbB Receptors
15
2020
302
1.360
Why?
Xenograft Model Antitumor Assays
26
2024
975
1.300
Why?
Receptor Cross-Talk
11
2015
37
1.290
Why?
Mice, Nude
32
2025
776
1.270
Why?
Phosphatidylinositol 3-Kinases
10
2019
359
1.200
Why?
Cyclin-Dependent Kinase 4
5
2024
67
1.200
Why?
Molecular Targeted Therapy
10
2025
403
1.190
Why?
Neoadjuvant Therapy
12
2023
399
1.110
Why?
Cyclin-Dependent Kinase 6
3
2024
50
1.100
Why?
Hepatocyte Nuclear Factor 3-alpha
4
2022
49
1.100
Why?
Neoplasms, Hormone-Dependent
6
2018
101
1.080
Why?
Estradiol
11
2022
550
1.060
Why?
Transcription Factor AP-1
5
2022
111
1.060
Why?
Class I Phosphatidylinositol 3-Kinases
6
2023
81
1.030
Why?
Genes, erbB-2
6
2013
38
1.020
Why?
PTEN Phosphohydrolase
4
2017
265
0.990
Why?
Estrogen Receptor Modulators
8
2008
39
0.970
Why?
Female
116
2025
70660
0.950
Why?
Biomarkers, Tumor
17
2024
1695
0.910
Why?
Cell Proliferation
27
2024
2532
0.860
Why?
Antineoplastic Agents, Immunological
2
2025
131
0.860
Why?
Protein Kinase Inhibitors
7
2025
608
0.830
Why?
Mice
58
2025
18709
0.820
Why?
Pyridines
3
2024
247
0.820
Why?
Humans
143
2025
132393
0.810
Why?
Piperazines
3
2024
256
0.800
Why?
Lymphocytes, Tumor-Infiltrating
2
2022
136
0.790
Why?
Estrogens
12
2022
521
0.780
Why?
Apoptosis
16
2024
1926
0.740
Why?
MCF-7 Cells
12
2021
231
0.740
Why?
Animals
66
2025
36116
0.720
Why?
Antibodies, Monoclonal, Humanized
15
2020
551
0.720
Why?
Gene Expression Profiling
12
2021
1903
0.710
Why?
Interferons
1
2022
145
0.700
Why?
Prognosis
22
2025
5029
0.680
Why?
Aromatase Inhibitors
6
2017
79
0.680
Why?
Precision Medicine
2
2019
354
0.630
Why?
Cinnamates
1
2018
15
0.610
Why?
Antibodies, Monoclonal
11
2013
1064
0.610
Why?
Circulating Tumor DNA
1
2018
39
0.580
Why?
Lymphocytes
1
2019
439
0.560
Why?
Indoles
1
2018
201
0.560
Why?
Gene Amplification
6
2019
247
0.560
Why?
DNA, Neoplasm
2
2017
317
0.550
Why?
Proto-Oncogene Proteins c-myc
4
2024
216
0.530
Why?
Neoplastic Cells, Circulating
4
2019
78
0.530
Why?
Receptors, Growth Factor
3
2005
37
0.510
Why?
Receptors, G-Protein-Coupled
4
2025
314
0.500
Why?
Interleukin-8
1
2016
220
0.490
Why?
Neoplastic Stem Cells
3
2019
349
0.480
Why?
RNA, Small Interfering
13
2018
714
0.480
Why?
Chromatin
4
2022
608
0.460
Why?
Tumor Microenvironment
4
2025
650
0.460
Why?
Tumor Cells, Cultured
12
2021
1101
0.450
Why?
Epidermal Growth Factor
5
2021
124
0.440
Why?
Growth Substances
4
2004
116
0.430
Why?
Transcriptome
4
2016
1104
0.420
Why?
Estrogen Antagonists
4
2022
105
0.400
Why?
Mammary Neoplasms, Experimental
5
2014
246
0.400
Why?
Sirolimus
1
2014
242
0.400
Why?
Up-Regulation
8
2016
906
0.400
Why?
Proto-Oncogene Proteins c-bcl-2
2
2015
183
0.400
Why?
Mucin-4
1
2012
11
0.390
Why?
Receptors, Progesterone
5
2015
893
0.380
Why?
Integrin beta1
1
2011
56
0.370
Why?
Phosphorylation
12
2021
1700
0.370
Why?
Carcinoma, Ductal, Breast
3
2022
90
0.370
Why?
Transcription, Genetic
8
2020
1752
0.360
Why?
Apoptosis Regulatory Proteins
1
2012
168
0.360
Why?
Oncogene Proteins
3
2021
149
0.360
Why?
Receptor Protein-Tyrosine Kinases
3
2018
142
0.350
Why?
Gene Expression
6
2020
1614
0.320
Why?
Mutation
12
2019
6233
0.320
Why?
Carcinoma
2
2015
321
0.310
Why?
Protein Kinases
4
2016
342
0.310
Why?
Adaptation, Physiological
2
2021
288
0.300
Why?
Estrogen Receptor beta
3
2008
86
0.300
Why?
Gold
3
2014
57
0.300
Why?
Cell Cycle
6
2024
628
0.300
Why?
Transplantation, Heterologous
8
2011
271
0.290
Why?
Triple Negative Breast Neoplasms
3
2018
261
0.290
Why?
Proteome
1
2010
279
0.290
Why?
Epigenesis, Genetic
4
2019
770
0.290
Why?
TOR Serine-Threonine Kinases
5
2020
458
0.290
Why?
Proto-Oncogene Proteins c-akt
6
2017
512
0.290
Why?
Fibroblasts
5
2022
913
0.290
Why?
Mitogen-Activated Protein Kinases
3
2014
214
0.280
Why?
Dyslexia
2
2019
30
0.280
Why?
Carcinogenesis
4
2025
361
0.280
Why?
Chemotherapy, Adjuvant
5
2019
397
0.270
Why?
Neoplasm Transplantation
9
2019
398
0.270
Why?
Transcription Factors
5
2019
2700
0.260
Why?
Histone Acetyltransferases
4
2020
317
0.260
Why?
Cell Transformation, Neoplastic
6
2014
645
0.260
Why?
Cellular Reprogramming
2
2020
121
0.250
Why?
Oligonucleotide Array Sequence Analysis
5
2016
1069
0.250
Why?
Neoplasm Staging
5
2025
1396
0.250
Why?
Gene Knockdown Techniques
6
2018
395
0.240
Why?
Genes, erbB-1
1
2005
10
0.240
Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 12
2
2018
19
0.240
Why?
Survival Analysis
4
2020
1593
0.230
Why?
RNA Interference
5
2019
544
0.230
Why?
Nanoshells
3
2014
13
0.230
Why?
Neoplasm Proteins
2
2020
716
0.220
Why?
Extracellular Matrix Proteins
1
2025
161
0.220
Why?
Membrane Proteins
1
2012
1604
0.220
Why?
Enzyme Inhibitors
4
2020
608
0.220
Why?
Heterografts
3
2022
193
0.220
Why?
Cyclin-Dependent Kinases
1
2024
90
0.220
Why?
Homeodomain Proteins
2
2019
585
0.210
Why?
Drugs, Investigational
1
2003
24
0.210
Why?
Blotting, Western
7
2011
1138
0.210
Why?
Carrier Proteins
3
2020
1060
0.210
Why?
Repressor Proteins
4
2014
862
0.200
Why?
Intercellular Signaling Peptides and Proteins
4
2014
294
0.200
Why?
Carcinoma, Lobular
1
2022
26
0.200
Why?
Drug Resistance
2
2018
263
0.200
Why?
Neoplasm Metastasis
5
2017
749
0.200
Why?
GATA3 Transcription Factor
2
2020
38
0.190
Why?
Clonal Evolution
2
2021
49
0.190
Why?
Phototherapy
2
2014
38
0.190
Why?
Receptors, Neuropeptide Y
1
2022
8
0.190
Why?
Endocrine Gland Neoplasms
1
2022
7
0.190
Why?
Treatment Outcome
14
2025
12861
0.190
Why?
Drug Synergism
2
2016
239
0.190
Why?
Remission Induction
2
2020
308
0.190
Why?
Middle Aged
16
2025
28944
0.190
Why?
Enhancer of Zeste Homolog 2 Protein
2
2021
67
0.180
Why?
F-Box Proteins
2
2019
37
0.180
Why?
Follow-Up Studies
3
2019
5439
0.180
Why?
Promoter Regions, Genetic
5
2019
1413
0.180
Why?
src-Family Kinases
4
2020
98
0.180
Why?
Attention
2
2019
211
0.170
Why?
Selective Estrogen Receptor Modulators
4
2022
61
0.170
Why?
p300-CBP Transcription Factors
1
2020
51
0.170
Why?
Proto-Oncogene Proteins
2
2021
598
0.160
Why?
Protein-Arginine N-Methyltransferases
1
2020
45
0.160
Why?
Nuclear Proteins
4
2020
1328
0.160
Why?
Thiophenes
1
2020
72
0.160
Why?
In Situ Hybridization, Fluorescence
2
2019
790
0.160
Why?
Mevalonic Acid
1
2019
21
0.160
Why?
Auditory Perception
1
2019
40
0.160
Why?
Cell Survival
6
2021
890
0.160
Why?
Aged
14
2025
21397
0.160
Why?
Keratins
2
2019
52
0.160
Why?
SOXB1 Transcription Factors
1
2019
63
0.160
Why?
NF-kappa B
1
2022
486
0.160
Why?
Single-Cell Analysis
2
2020
340
0.160
Why?
Phenotype
9
2016
4491
0.150
Why?
Integrin alpha6
1
2018
6
0.150
Why?
Bone and Bones
1
2021
303
0.150
Why?
Trans-Activators
1
2003
827
0.150
Why?
Visual Perception
1
2019
134
0.150
Why?
Dendritic Cells
1
2022
447
0.150
Why?
Executive Function
1
2019
124
0.150
Why?
Proteogenomics
1
2020
95
0.150
Why?
Oncogene Proteins, Fusion
1
2020
226
0.150
Why?
Mice, SCID
3
2019
612
0.150
Why?
Protein-Tyrosine Kinases
4
2024
230
0.140
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2018
36
0.140
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2025
753
0.140
Why?
Adult
15
2025
31578
0.140
Why?
Receptors, Aryl Hydrocarbon
1
2018
66
0.140
Why?
Flavonoids
1
2018
87
0.140
Why?
RNA, Messenger
6
2010
2894
0.140
Why?
Lasers
2
2014
117
0.140
Why?
Proteomics
2
2013
580
0.140
Why?
Protein Binding
5
2020
1830
0.130
Why?
SOX9 Transcription Factor
1
2017
84
0.130
Why?
Disease Models, Animal
8
2021
4699
0.130
Why?
Receptors, Cell Surface
1
2018
495
0.120
Why?
Cytokines
1
2022
1395
0.120
Why?
Oxidative Stress
1
2000
859
0.120
Why?
Chlorophyll
1
2014
5
0.120
Why?
Receptor, ErbB-4
1
2015
9
0.120
Why?
Drug Liberation
1
2014
28
0.120
Why?
Tumor Burden
2
2014
257
0.120
Why?
Mice, Inbred NOD
2
2013
316
0.120
Why?
Reading
1
2015
84
0.120
Why?
Immunohistochemistry
5
2015
1760
0.120
Why?
Genomic Instability
1
2016
243
0.120
Why?
Photochemistry
1
2014
22
0.110
Why?
Ribonucleoside Diphosphate Reductase
1
2014
13
0.110
Why?
Genes, myc
2
2011
107
0.110
Why?
Nanotechnology
1
2014
51
0.110
Why?
MAP Kinase Kinase Kinase 3
1
2014
9
0.110
Why?
Mitochondrial Proteins
2
2013
243
0.110
Why?
Mice, Inbred BALB C
3
2019
1083
0.110
Why?
Hyperthermia, Induced
1
2014
58
0.110
Why?
Language
1
2015
218
0.110
Why?
Mammary Neoplasms, Animal
2
2005
140
0.110
Why?
Cell Differentiation
1
2022
2025
0.110
Why?
Liposomes
1
2014
203
0.110
Why?
Phosphatidylinositols
1
2013
32
0.110
Why?
Doxycycline
1
2014
121
0.110
Why?
Glutarates
1
2013
38
0.110
Why?
Down-Regulation
5
2021
714
0.110
Why?
Metal Nanoparticles
1
2014
59
0.110
Why?
Acneiform Eruptions
1
2013
4
0.110
Why?
Cell Membrane
2
2013
485
0.100
Why?
Nuclear Receptor Coactivator 3
3
2010
350
0.100
Why?
DNA Mutational Analysis
1
2015
837
0.100
Why?
Drug Eruptions
1
2013
32
0.100
Why?
Random Allocation
1
2014
450
0.100
Why?
Proto-Oncogene Proteins c-ets
1
2013
60
0.100
Why?
Histone-Lysine N-Methyltransferase
1
2014
170
0.100
Why?
Cytoplasm
2
2011
303
0.100
Why?
Neoplasms
3
2014
2984
0.100
Why?
Heat-Shock Proteins
1
2013
203
0.100
Why?
Tumor Suppressor Proteins
3
2011
506
0.100
Why?
Gene Rearrangement
1
2014
332
0.100
Why?
CD24 Antigen
1
2012
32
0.100
Why?
Mammary Glands, Human
2
2010
83
0.100
Why?
Hyaluronan Receptors
1
2012
68
0.100
Why?
Genomics
1
2020
1658
0.100
Why?
Models, Biological
3
2008
1531
0.090
Why?
Kaplan-Meier Estimate
3
2025
1131
0.090
Why?
Ubiquitin-Activating Enzymes
1
2011
23
0.090
Why?
Focal Adhesion Kinase 1
1
2011
26
0.090
Why?
Paclitaxel
1
2012
141
0.090
Why?
Mitogen-Activated Protein Kinase 3
2
2010
97
0.090
Why?
Lung Neoplasms
2
2019
1778
0.090
Why?
Statistics, Nonparametric
1
2012
454
0.090
Why?
Mitogen-Activated Protein Kinase 1
2
2010
114
0.090
Why?
cdc42 GTP-Binding Protein
1
2010
32
0.090
Why?
Eukaryotic Initiation Factor-3
1
2010
8
0.090
Why?
Insulin-Like Growth Factor I
2
2010
353
0.090
Why?
Lentivirus
1
2011
86
0.090
Why?
Ovariectomy
2
2008
188
0.090
Why?
Antigens, Viral, Tumor
1
2010
47
0.090
Why?
Polyomavirus
1
2010
32
0.090
Why?
Diagnostic Imaging
2
2011
306
0.090
Why?
Genetic Techniques
1
2011
109
0.090
Why?
Receptor, IGF Type 1
2
2008
95
0.090
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
1326
0.080
Why?
Tumor Necrosis Factor-alpha
2
2014
712
0.080
Why?
Cell Division
3
2007
772
0.080
Why?
Protein Processing, Post-Translational
2
2011
384
0.080
Why?
Antibodies
1
2011
382
0.080
Why?
Immunoconjugates
1
2010
44
0.080
Why?
Proto-Oncogene Proteins p21(ras)
1
2010
177
0.080
Why?
Proteasome Endopeptidase Complex
1
2010
270
0.080
Why?
MAP Kinase Kinase 5
1
2008
4
0.080
Why?
Mitogen-Activated Protein Kinase 7
1
2008
11
0.080
Why?
Triazoles
3
2015
142
0.080
Why?
Gene Silencing
3
2016
249
0.080
Why?
Aged, 80 and over
7
2019
7133
0.080
Why?
Mesoderm
1
2008
112
0.070
Why?
Transfection
4
2013
1090
0.070
Why?
Heparin-binding EGF-like Growth Factor
1
2008
14
0.070
Why?
Endocrine System
1
2008
22
0.070
Why?
Receptors, CXCR4
1
2008
69
0.070
Why?
Reproducibility of Results
4
2020
3045
0.070
Why?
Epithelium
1
2008
370
0.070
Why?
Indium Radioisotopes
1
2007
9
0.070
Why?
Nanoparticles
1
2010
282
0.070
Why?
Protein Biosynthesis
1
2010
676
0.070
Why?
Laser Therapy
1
2010
251
0.070
Why?
Organometallic Compounds
1
2007
116
0.070
Why?
Genetic Vectors
1
2011
964
0.070
Why?
Radiopharmaceuticals
1
2007
194
0.070
Why?
Receptors, Somatotropin
1
2006
9
0.060
Why?
Gene Dosage
1
2008
456
0.060
Why?
Cell Separation
2
2019
234
0.060
Why?
Neoplasm Recurrence, Local
3
2022
1295
0.060
Why?
Carcinoma, Renal Cell
1
2008
251
0.060
Why?
Clinical Trials, Phase II as Topic
2
2020
81
0.060
Why?
Clinical Trials as Topic
1
2011
1148
0.060
Why?
Polyamines
1
2005
29
0.060
Why?
Human Growth Hormone
1
2006
78
0.060
Why?
Intracellular Signaling Peptides and Proteins
1
2008
590
0.060
Why?
Disease-Free Survival
3
2015
971
0.060
Why?
Laminin
1
2025
70
0.060
Why?
Cell Cycle Proteins
3
2014
694
0.060
Why?
p38 Mitogen-Activated Protein Kinases
1
2005
131
0.060
Why?
Protein Kinase C
1
2005
153
0.060
Why?
Silicon Dioxide
2
2014
30
0.060
Why?
JNK Mitogen-Activated Protein Kinases
2
2002
93
0.060
Why?
DNA Methylation
3
2017
1140
0.050
Why?
Particle Size
2
2014
144
0.050
Why?
Kidney Neoplasms
1
2008
459
0.050
Why?
Forecasting
1
2005
375
0.050
Why?
Genome-Wide Association Study
1
2011
1856
0.050
Why?
Proportional Hazards Models
3
2015
1471
0.050
Why?
Nitriles
2
2015
155
0.050
Why?
Receptors, Retinoic Acid
1
2003
98
0.050
Why?
Drug Evaluation, Preclinical
1
2003
157
0.050
Why?
Acetyltransferases
1
2003
91
0.050
Why?
Nuclear Receptor Coactivator 1
1
2003
244
0.050
Why?
Neoplasm Invasiveness
2
2015
657
0.050
Why?
Tissue Array Analysis
2
2014
143
0.050
Why?
Polyethylene Glycols
2
2014
250
0.050
Why?
Tetrahydronaphthalenes
1
2022
29
0.050
Why?
Cadherins
1
2003
184
0.050
Why?
Genetic Predisposition to Disease
1
2013
3443
0.050
Why?
Computational Biology
2
2020
881
0.050
Why?
Phosphatidylinositol 3-Kinase
1
2021
27
0.050
Why?
Resting Phase, Cell Cycle
1
2021
18
0.050
Why?
Neoplasm Micrometastasis
1
2021
13
0.050
Why?
Cyclin-Dependent Kinase Inhibitor p27
1
2021
62
0.050
Why?
CRISPR-Cas Systems
1
2024
282
0.050
Why?
Metabolome
2
2014
309
0.050
Why?
Dose-Response Relationship, Drug
2
2021
1726
0.050
Why?
Cell Cycle Checkpoints
1
2021
62
0.050
Why?
Gap Junctions
1
2021
40
0.040
Why?
G1 Phase
1
2021
68
0.040
Why?
Chloramphenicol O-Acetyltransferase
1
2000
80
0.040
Why?
Proto-Oncogene Proteins c-jun
1
2000
37
0.040
Why?
Pentose Phosphate Pathway
1
2000
44
0.040
Why?
Gene Ontology
1
2020
55
0.040
Why?
Cell Line
3
2011
2836
0.040
Why?
Lipid Peroxidation
1
2000
98
0.040
Why?
Dasatinib
1
2020
50
0.040
Why?
Cell Movement
2
2014
918
0.040
Why?
Lymphatic Metastasis
2
2013
454
0.040
Why?
Cell Communication
1
2021
186
0.040
Why?
Glutathione Transferase
1
2000
165
0.040
Why?
Molecular Conformation
1
2020
110
0.040
Why?
Genes, Reporter
1
2021
394
0.040
Why?
Superoxide Dismutase
1
2000
185
0.040
Why?
Osteogenesis
1
2021
167
0.040
Why?
Biopsy, Large-Core Needle
1
2020
34
0.040
Why?
Flow Cytometry
2
2014
835
0.040
Why?
Clinical Trials, Phase III as Topic
1
2020
75
0.040
Why?
Green Fluorescent Proteins
1
2021
397
0.040
Why?
Acetylation
1
2020
182
0.040
Why?
Cyclopentanes
1
2019
22
0.040
Why?
Molecular Docking Simulation
1
2020
127
0.040
Why?
Gonadal Steroid Hormones
1
2020
98
0.040
Why?
Fluorescent Antibody Technique
2
2011
433
0.040
Why?
Protein Isoforms
3
2008
426
0.040
Why?
Molecular Structure
1
2020
316
0.040
Why?
Enzyme Activation
2
2010
646
0.040
Why?
Leukocyte Common Antigens
1
2019
93
0.040
Why?
Epithelial Cells
2
2014
938
0.040
Why?
Ubiquitination
1
2019
181
0.040
Why?
Structure-Activity Relationship
1
2020
604
0.040
Why?
Mechanistic Target of Rapamycin Complex 1
1
2019
171
0.040
Why?
Oncogene Protein v-akt
1
2018
34
0.040
Why?
Drug Discovery
1
2020
180
0.040
Why?
Mice, Transgenic
3
2010
2494
0.040
Why?
Mice, Knockout
2
2019
3933
0.040
Why?
Transcriptional Activation
1
2020
496
0.040
Why?
Drug Administration Schedule
2
2013
745
0.040
Why?
Oncogene Addiction
1
2017
3
0.040
Why?
Time Factors
3
2015
6519
0.040
Why?
Predictive Value of Tests
1
2003
2280
0.030
Why?
Benzimidazoles
1
2018
136
0.030
Why?
Adaptor Proteins, Signal Transducing
2
2014
610
0.030
Why?
Ligands
1
2018
570
0.030
Why?
G2 Phase Cell Cycle Checkpoints
1
2016
9
0.030
Why?
Extracellular Signal-Regulated MAP Kinases
2
2008
149
0.030
Why?
MAP Kinase Signaling System
2
2011
324
0.030
Why?
Microscopy, Confocal
2
2010
368
0.030
Why?
Bone Neoplasms
1
2021
453
0.030
Why?
Pyrimidines
1
2019
412
0.030
Why?
Cell Nucleus
1
2019
688
0.030
Why?
Linguistics
1
2015
20
0.030
Why?
Epithelial-Mesenchymal Transition
1
2017
244
0.030
Why?
Breast
1
2017
219
0.030
Why?
DNA, Complementary
2
2011
471
0.030
Why?
Models, Molecular
1
2019
1127
0.030
Why?
Drug Design
1
2016
167
0.030
Why?
Pilot Projects
1
2020
1467
0.030
Why?
Young Adult
2
2019
9728
0.030
Why?
Fluoresceins
1
2014
36
0.030
Why?
Bias
1
2015
147
0.030
Why?
Luminescent Measurements
1
2014
61
0.030
Why?
Immunoblotting
1
2015
317
0.030
Why?
Lasers, Semiconductor
1
2014
9
0.030
Why?
Photic Stimulation
1
2015
234
0.030
Why?
Transducers
1
2014
26
0.030
Why?
Nanomedicine
1
2014
24
0.030
Why?
Ki-67 Antigen
1
2014
117
0.030
Why?
Photochemotherapy
1
2014
47
0.030
Why?
Surface Properties
1
2014
95
0.030
Why?
Survival Rate
1
2019
2186
0.030
Why?
Injections, Intravenous
1
2014
254
0.030
Why?
Materials Testing
1
2014
78
0.030
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2014
24
0.030
Why?
Tissue Distribution
1
2014
404
0.030
Why?
Light
1
2014
183
0.030
Why?
Alcohol Oxidoreductases
1
2013
22
0.030
Why?
Colony-Forming Units Assay
1
2014
70
0.030
Why?
Azepines
1
2014
65
0.030
Why?
Open Reading Frames
1
2014
220
0.030
Why?
Solubility
1
2013
144
0.030
Why?
Proteolysis
1
2014
187
0.030
Why?
Etoposide
1
2014
120
0.030
Why?
Disease Progression
2
2013
2208
0.030
Why?
Fluorouracil
1
2014
141
0.030
Why?
Culture Media, Serum-Free
2
2003
23
0.030
Why?
fas Receptor
1
2013
50
0.030
Why?
Nuclear Receptor Co-Repressor 1
2
2003
55
0.030
Why?
Epigenomics
1
2014
189
0.030
Why?
DNA Damage
1
2016
541
0.030
Why?
Optics and Photonics
1
2014
141
0.030
Why?
Isocitrate Dehydrogenase
1
2013
80
0.030
Why?
Sequence Analysis, DNA
1
2019
1832
0.020
Why?
Mass Spectrometry
1
2014
369
0.020
Why?
In Vitro Techniques
1
2014
992
0.020
Why?
Plasmids
1
2013
525
0.020
Why?
Glutamine
1
2013
222
0.020
Why?
Doxorubicin
1
2014
304
0.020
Why?
Wnt Signaling Pathway
1
2013
205
0.020
Why?
Spindle Apparatus
1
2011
50
0.020
Why?
Sumoylation
1
2011
38
0.020
Why?
Sequence Analysis, RNA
1
2014
428
0.020
Why?
Immunoenzyme Techniques
1
2011
260
0.020
Why?
Image Processing, Computer-Assisted
1
2014
622
0.020
Why?
Luminescence
1
2011
18
0.020
Why?
Foreskin
1
2010
4
0.020
Why?
Mitosis
1
2011
194
0.020
Why?
Electromagnetic Fields
1
2010
28
0.020
Why?
F-Box-WD Repeat-Containing Protein 7
1
2010
23
0.020
Why?
Polyribosomes
1
2010
26
0.020
Why?
NIH 3T3 Cells
1
2010
96
0.020
Why?
Multicenter Studies as Topic
1
2011
287
0.020
Why?
Taxoids
1
2010
72
0.020
Why?
Fluorescence
1
2010
103
0.020
Why?
Recombinant Fusion Proteins
1
2013
794
0.020
Why?
Sphingosine
1
2010
17
0.020
Why?
Metabolomics
1
2014
448
0.020
Why?
Placebos
1
2011
240
0.020
Why?
Lysophospholipids
1
2010
33
0.020
Why?
Guanine Nucleotide Exchange Factors
1
2010
93
0.020
Why?
Frozen Sections
1
2010
31
0.020
Why?
Histones
1
2014
566
0.020
Why?
Phosphotransferases (Alcohol Group Acceptor)
1
2010
79
0.020
Why?
Ribosomes
1
2010
138
0.020
Why?
p21-Activated Kinases
1
2010
58
0.020
Why?
RNA-Binding Proteins
1
2014
598
0.020
Why?
Spectroscopy, Near-Infrared
1
2010
151
0.020
Why?
Fluorine Radioisotopes
1
2009
13
0.020
Why?
Dideoxynucleosides
1
2009
10
0.020
Why?
Genome, Human
1
2016
1344
0.020
Why?
Algorithms
1
2016
1721
0.020
Why?
Cell Death
1
2010
249
0.020
Why?
Cellular Senescence
1
2010
199
0.020
Why?
Electrophoresis, Gel, Two-Dimensional
1
2008
47
0.020
Why?
Tumor Stem Cell Assay
1
2008
37
0.020
Why?
S-Phase Kinase-Associated Proteins
1
2008
20
0.020
Why?
Prospective Studies
2
2013
6561
0.020
Why?
Multivariate Analysis
1
2012
1484
0.020
Why?
Cyclin D1
1
2008
123
0.020
Why?
Mitochondria
1
2013
737
0.020
Why?
Fluorodeoxyglucose F18
1
2009
167
0.020
Why?
Case-Control Studies
1
2015
3605
0.020
Why?
Drug-Related Side Effects and Adverse Reactions
1
2011
280
0.020
Why?
Ubiquitin-Protein Ligases
1
2010
382
0.020
Why?
Chromatography, Liquid
1
2008
229
0.020
Why?
Genes, Tumor Suppressor
1
2008
224
0.020
Why?
Mammary Glands, Animal
1
2011
476
0.020
Why?
Tomography, Emission-Computed, Single-Photon
1
2007
108
0.020
Why?
Logistic Models
1
2012
1896
0.020
Why?
Positron-Emission Tomography
1
2009
343
0.020
Why?
Tandem Mass Spectrometry
1
2008
278
0.020
Why?
Src Homology 2 Domain-Containing, Transforming Protein 1
1
2005
2
0.020
Why?
Dendrimers
1
2005
5
0.020
Why?
Shc Signaling Adaptor Proteins
1
2005
12
0.020
Why?
Rhodamines
1
2005
22
0.020
Why?
Binding, Competitive
1
2005
194
0.020
Why?
Mitogens
1
2005
32
0.020
Why?
Acetophenones
1
2005
13
0.020
Why?
Biomarkers
1
2015
3373
0.020
Why?
Benzopyrans
1
2005
21
0.020
Why?
Protein Kinase C-delta
1
2005
17
0.020
Why?
Wnt1 Protein
1
2005
73
0.010
Why?
Confidence Intervals
1
2005
301
0.010
Why?
Phosphoric Monoester Hydrolases
1
2005
109
0.010
Why?
Glucose
1
2009
916
0.010
Why?
Genes, p53
1
2005
234
0.010
Why?
Extracellular Matrix
1
2005
251
0.010
Why?
Wnt Proteins
1
2005
223
0.010
Why?
Microscopy, Fluorescence
1
2005
337
0.010
Why?
MicroRNAs
1
2011
944
0.010
Why?
Cell Line, Transformed
1
2003
170
0.010
Why?
Infusions, Intravenous
1
2005
570
0.010
Why?
Age Factors
1
2010
2960
0.010
Why?
Antibody Specificity
1
2003
206
0.010
Why?
Genome
1
2005
520
0.010
Why?
Genes, Dominant
1
2003
254
0.010
Why?
Antigens, Neoplasm
1
2005
406
0.010
Why?
Odds Ratio
1
2005
1333
0.010
Why?
Kidney
1
2008
1402
0.010
Why?
Biopsy
1
2005
1299
0.010
Why?
Male
2
2019
64985
0.010
Why?
DNA
1
2005
1662
0.010
Why?
Tomography, X-Ray Computed
1
2007
2208
0.010
Why?
Magnetic Resonance Imaging
1
2010
3824
0.010
Why?
Osteosarcoma
1
1999
265
0.010
Why?
Gene Expression Regulation
1
2005
2656
0.010
Why?
Retrospective Studies
1
2011
17174
0.010
Why?
SCHIFF's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (507)
Explore
_
Co-Authors (66)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_